Lifeng Wang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
Papers in
-
- Lung Cancer Treatments and Mutations 12
- Ferroptosis and cancer prognosis 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 1
- Co-authors
- Baorui Liu (20 shared papers)Jia Wei (7 shared papers)Rutian Li (14 shared papers)Lixia Yu (13 shared papers)Xiaoping Qian (5 shared papers)Haitao Yin (2 shared papers)Hanqing Qian (3 shared papers)Yang Zhao (3 shared papers)
- Journals
- BMC Cancer (2 papers)International Journal of Nanomedicine (2 papers)Journal of Biomedical Nanotechnology (2 papers)Cancer Management and Research (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Lifeng Wang
39 papers receiving 883 citations
Peers
Comparison fields: 5 of 69
- Biomaterials 151
- Oncology 255
- Drug Discovery 3
- Cancer Research 93
- Pulmonary and Respiratory Medicine 175
Countries citing papers authored by Lifeng Wang
This map shows the geographic impact of Lifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Wang more than expected).
Fields of papers citing papers by Lifeng Wang
This network shows the impact of papers produced by Lifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Wang. The network helps show where Lifeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lifeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 121 | |
| 2 | 2020 | 111 | |
| 3 | 2020 | 91 | |
| 4 | 2008 | 88 | |
| 5 | 2014 | 77 | |
| 6 | 2010 | 44 | |
| 7 | 2021 | 36 | |
| 8 | 2020 | 30 | |
| 9 | 2020 | 30 | |
| 10 | 2008 | 28 | |
| 11 | 2017 | 28 | |
| 12 | 2020 | 28 | |
| 13 | 2018 | 27 | |
| 14 | 2009 | 21 | |
| 15 | 2003 | 20 | |
| 16 | 2017 | 15 | |
| 17 | 2016 | 13 | |
| 18 | 2012 | 12 | |
| 19 | 2017 | 9 | |
| 20 | 2018 | 9 |
About Lifeng Wang
Lifeng Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biomaterials, Cancer Research and Pharmacology, having authored 42 papers that have together received 905 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Nanoparticle-Based Drug Delivery (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (3 papers), Ferroptosis and cancer prognosis (2 papers), Inflammatory mediators and NSAID effects (1 paper), Phytochemicals and Antioxidant Activities (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Biomaterials (151 citations), Oncology (255 citations), Drug Discovery (3 citations), Cancer Research (93 citations) and Pulmonary and Respiratory Medicine (175 citations). Lifeng Wang has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Baorui Liu, Jia Wei, Rutian Li, Lixia Yu, Xiaoping Qian, Haitao Yin, Hanqing Qian, Yang Zhao, Lianru Zhang and Jie Shao. Their work appears in journals such as BMC Cancer, International Journal of Nanomedicine, Journal of Biomedical Nanotechnology, Cancer Management and Research and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.